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rises with the age. 75% of the disease occurs after age 50. 
Unfortunately up to 10% of breast cancers are diagnosed 
as metastatic at first examination, what leads to low, not 
more than 20% of 5 years survival. The involvement of 
axillar nodes is an important factor in the prognosis of 
relapse of the disease. Up to 3/4 of node-positive breast 
cancers will relapse. The reason for the high prevalence 
of metastatic disease is that many women live with their 
disease till the first visit to the doctor.
The diagnosis is based on self-exam, clinical and radio-
logical examination, fine needle aspiration biopsy and 
pathological sample examination. Although low specificity 
of the Breast self-exam (BSE) it is still a valuable tool for 
detection of the disease, especially in women age >41, be-
cause of prevalence of the fatty tissue3.
Breast cancer is today the most common cancer in 
women in Western Europe, as almost in all countries. The 
age-standardized incidence in Europe was 62.8/100,000 
and the mortality—16.7/100,000 women/year. The age-
standardized incidence in Croatia in 2011 was 
68.8/100,000 and the mortality—24.3/100,000 women/
year1. In the last 2 decades the incidence rate has in-
creased annually. The incidence is increasing due to mam-
mography screening and with aging of the population. To 
the rising incidence contribute several factors, as post-
menopausal hormone replacement therapy, obesity and 
consumption of alcohol and tobacco. On the other hand to 
the reducing of the mortality rate conduce detecting of the 
tumor in earlier stages, and new systemic therapy mo-
dalities. However, Breast Cancer is still the leading cause 
of cancer death in women2. The prevalence of the disease 
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A B S T R A C T
Breast cancer is the most common cancer in women in Western countries after skin tumors. Successful treatment de-
pends on many factors, relies on clinical examination, diagnostic procedures, pathologic evaluation, and good therapy 
decision. The Pathologic diagnosis should be the determining factor in the decision on therapeutic approach. There are 
several methods of obtaining tissue samples. The percutaneous ultrasound guided breast Core needle biopsy (CNB) is one 
of them. The Aim of this Study is to evaluate our experience in the accuracy of hormone receptors assessment in ultrasound 
guided CNB. In our institution, in last 12 month 60 women (with 67 lesions) underwent Breast CNB. The CNB was 
performed with 16 Gauge semiautomatic biopsy needle with 15 Gauge coordinated introducer needle. 3–6 specimen (mean 
4) were taken during the procedure. We analyzed five factors (histological type, histological grade, estrogen and proges-
terone receptor status, and HER2 from the biopsied sample. All results were presented at the Multidisciplinary Oncology 
Team. In addition to demographic data and morphological features of the lesion, we analyzed five pathological factors 
(histological type, histological grade, estrogen and progesterone receptor status, and HER2 from the biopsied sample. All 
results were presented at the Multidisciplinary Oncology Team. Ultrasound-guided CNB has proven to be a reliable 
technique for performing a biopsy for breast. It is a good and reliable, complication free method, for preoperative staging, 
operative planning as well for prognostic value. It is a cost-effective method, can be performed quickly and in outpatient 
population, does not deform the breast and multiple lesions can be biopsied. This technique shows a high sensitivity 
value and offers many advantages over other imaging methods to guide a biopsy. All advantages have made this technique 
the most widespread used technique to perform a biopsy for a suspicious breast lesion.
Key words: core needle biopsy, multidisciplinary oncology team, breast carcinoma
Introduction
Received for publication June 15, 2014
924
A. Pal et al.: Hormone Receptor assessment in Breast Biopsy, Coll. Antropol. 39 (2015) 4: 923–925
Clinical examination (CBE) includes bimanual palpa-
tion of the breasts and loco regional lymph nodes. In spite 
that CBE leads to greater risk of false positive results, it 
has a modest benefit than mammography alone, especial-
ly in dense breasts4.
Radiological examinations include bilateral mammog-
raphy and ultrasound of the breasts (and regional lymph 
nodes depending on local expertise).
Mammography can be performed as screening mam-
mography and as diagnostic mammography in women 
with symptoms of breast disease. The goal of mammogra-
phy is to detect and to characterize the disease in asymp-
tomatic women, and to evaluate the findings. Annual 
screening mammography is today the only imaging mo-
dality that reduces breast cancer mortality, especially in 
age appropriate women. Magnetic resonance imaging 
(MRI) of the breast should not be used as a routine proce-
dure, but may be considered in women with BRCA muta-
tion, in cases with multifocal breast cancers, and in young 
women with dense breast where carcinoma is suspected. 
Also it should be considered in women with silicone im-
plants, and recurrent disease. FNAB is an accurate meth-
od for evaluating breast malignancy if rigorous criteria 
are used. In the case of malignant finding invasive proce-
dures are required. The pathological diagnosis should be 
based on core needle biopsy (CNB) obtained by ultrasound 
or stereotactic, guidance or as open surgical procedure. A 
core needle biopsy should be obtained for the decision of 
appropriate therapeutic approach. If the decision am op-
erative removal malignant lump is, a surgical clip should 
be placed into the tumor at biopsy to facilitate the later 
surgical resection.
Materials and Methods
Ultrasound-guided CNB of the breast is an unavoid-
able method for taking a sample of pathological changed 
breast tissue suspected for malignant detected on ultra-
sound5. Highly suggestive of malignancy are lesions BI_
RADS 4–5 Category (Breast Imaging-Reporting and Data 
System [BI-RADS®] category 4 and 5 lesions). When this 
procedure is performed according to professional criteria 
the diagnostic accuracy is comparable to open surgical 
tissue sampling. Ultrasound guided Core needle biopsy is 
less difficult, time consuming, costly effective, has low risk 
of complication and multiple lesions can be biopsied com-
pared to open surgery. On the another hand Core-needle 
biopsy is more accurate than fine-needle aspiration and 
provides core samples of sufficient quality to stain for 
markers, which can guide to decision of appropriate ther-
apeutic approach, operative or neo-adjuvant treatment. 
Before attempting a breast biopsy, the radiologist should 
be familiar with all aspects of this procedure, should 
choose the most appropriate biopsy device, must provide 
safe and effective handling of the equipment and provide 
the patient with post biopsy care and instructions. Before 
the procedure, all patients underwent different imaging 
modalities, ending with Ultrasound examination. In-
formed Consent was obtained before the procedure with 
detailed explanation of the procedure, possible complica-
tions and expected result. Risk was discussed, and all 
patients were asked to come 2 days after the procedure for 
a control ultrasound for checkup for possible complica-
tions.
Results
In last 12 month in our Hospital we performed 60 CNB 
of the breast (with 67 lesions) using 16G Disposable semi-
automatic Guillotine Needle 25 mm Notch with 15G In-
troducer Needle. Before the procedure local anesthesia 
and disinfection of the skin was performed. Minimal inci-
sion before the procedure is usually obtained. 3–6 (mean 
4) specimen were taken, and sent to the pathologist. The 
finding was completed in at last 10 days. The result was 
presented to the multidisciplinary Oncological team, where 
the bet therapeutic approach was discussed. This article 
presents our experience in ultrasound-guided core-needle 
breast biopsies. The mean age of our patients was 66.8 
years.
From those 53 (79.1%), whose tissue diagnosis by CNB 
was Carcinoma, 40 (59.7%) entered this study. We ana-
lyzed five factors (histological type, histological grade, 
estrogen and progesterone receptor status (ER, PR), and 
HER2 from the biopsied sample. The tumor histology as 
well the number and the value of Hormone Receptor in 
each category was analyzed. From 40 positive for invasive 
carcinoma, 10 (25%) were specified as ductal invasive car-
cinoma, 4 (10%) as lobular invasive carcinoma, and in 26 
(65%) were unspecified. The Estrogen and Progesteron 
status was positive in 34 (85%) in the whole group, and 
each of them had Her2 status negative. The proliferation 
index was analyzed using Ki-67 status, and was low (less 
than 20 cells) in 20 carcinomas, while it was high in (more 
than 20 cells) in 12 (30%) of cases.
Discussion
Ultrasound-guided CNB has proven to be a reliable 
technique for performing a biopsy for breast lesions that 
can be clearly seen on ultrasound. The use of 16 Gauge 
needle is accurate, safe and a complication free method. It 
is a good and reliable method for preoperative staging, 
operative planning as well for prognostic value. This tech-
nique shows a high sensitivity value and offers many ad-
vantages over other imaging and non imaging methods to 
guide a biopsy. It is a cost-effective method, can be per-
formed quickly and in outpatient population, does not de-
form the breast and multiple lesions can be biopsied. 
All advantages have made this technique the most wide-
spread used technique to perform a biopsy for a suspicious 
breast lesion.
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VRIJEDNOST PROCJENE HORMONALNIH RECEPTORA KOD ULTRAZVUČNO VOĐENE BIOPSIJE 
DOJKE ŠIROKOM IGLOM
S A Ž E T A K
Rak dojke je najčešći rak u žena u zapadnim zemljama, nakon tumora kože. Uspješno liječenje ovisi o mnogim čim-
be nicima, a ovisi o kliničkom pregledu, dijagnostičkim postupcima, ocjeni patološkog nalaza, kao i odluci o vrsti terapi-
jskog zahvata. Patološka dijagnoza bi trebala biti odlučujući faktor u odluci o terapijskom pristupu. Postoji nekoliko 
načina za dobivanje uzoraka tkiva. Perkutana ultrazvučno vođena dojke debelom iglom (CNB) je jedna od njih. Cilj ovog 
rada je ocijeniti naše iskustvo u točnost određivanja hormonskih receptora u materijalu dobivenom ultrazvukom vođenom 
CNB. U našoj ustanovi, u posljednjih 12 mjeseci kod 60 žena (sa 67 lezija) izvršena je CNB. CNB je učinjena sa poluau-
tomatskom iglom debljine 16G, koristeći uvodnicu debljine 15G. Pored demografskih podataka i morfoloških obilježja 
lezije, analizirali smo pet patološka čimbenika (histološki tip, histološki stupanj, estrogena i progesterona status recep-
tora i HER2 iz biopsije uzorka Svi su rezultati predstavljeni na multidisciplinarnom onkologiju tima. Ultrazvukom 
vođena CNB se pokazala pouzdanom tehnikom za uzimanje materijala za histološku analizu. To je dobra, pouzdana i 
jeftina metoda, sa malom učestalošću komplikacija. Pokazala se kao pouzdana metoda u preoperativnom prikazu promje-
ne, operativnom planiranju, ali i kao dobra prognostička vrijednost. Na ovaj ekonomičan način, može se izvesti brzo i za 
ambulantne pacijente. Metoda ne deformira dojku i više lezije se može uzeti odjednom. Ova tehnika uzimanja histološkog 
materijala pokazuje visoku osjetljivost i nudi mnoge prednosti u odnosu na druge metode oslikavanja. Sve ove prednos-
ti su učinile da je tehnika postala  najraširenijim načinom uzimanja materijala za histološku analizu koristi tehniku 
sumnjivih lezija dojke.
